Pharmacokinetics of Oral Acyclovir in Neonates and in Infants: a Population Analysis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.45.1.150-157.2001PMID 11120958PMCID PMC90253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aciclovir

  2012cited by this paper
• A double-blind, randomized study assessing the equivalence of valacyclovir 1000 mg once daily versus 500 mg twice daily in the episodic treatment of recurrent genital herpes. Genival Study Group.

  1999cited by this paper
• A double-blind, randomized study assessing the equivalence of valacyclovir 1000 mg once daily versus 500 mg twice daily in the episodic treatment of recurrent genital herpes

  1999cited by this paper
• Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group.

  1998cited by this paper
• Management of herpes simplex and varicella-zoster virus infections.

  1997cited by this paper
• A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.

  1996cited by this paper
• A Size Standard for Pharmacokinetics

  1996cited by this paper
• Population pharmacokinetic study of isepamicin with intensive care unit patients

  1996cited by this paper
• Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.

  1996cited by this paper
• Dosing considerations for oral acyclovir following neonatal herpes disease

  1994cited by this paper
• Pharmacokinetics for the Pharmaceutical Scientist

  1993cited by this paper
• Comparative Pharmacokinetics of Antiviral Nucleoside Analogues

  1993cited by this paper
• Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

  1992cited by this paper
• Evaluation of hypothesis testing for comparing two populations using NONMEM analysis

  1992cited by this paper
• Population pharmacokinetics/dynamics.

  1992cited by this paper
• A three-step approach combining bayesian regression and NONMEM population analysis: Application to midazolam

  1991cited by this paper
• Geigy Scientific Tables

  1991cited by this paper
• The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.

  1987influential reference
• Pharmacokinetics of acyclovir suspension in infants and children

  1987cited by this paper
• Clinical Pharmacokinetics of Acyclovir

  1983cited by this paper
• Neonatal acyclovir pharmacokinetics in patients with herpes virus infections.

  1982cited by this paper
• Overview of acyclovir pharmacokinetic disposition in adults and children.

  1982cited by this paper

• Revisiting Acyclovir Dosing for Adult Viral Encephalitis Using a Full Bayesian LeiCNS PBPK Modeling Approach

  2025influential citation
• Herpes simplex virus - state of the art of prevention and treatment.

  2025cites this paper
• Distribution of acyclovir in central nervous system compartments: a porcine pharmacokinetic model

  2025influential citation
• Revisiting acyclovir dosing for viral encephalitis using a Bayesian PBPK modeling approach

  2024influential citation
• Management of neonatal central nervous system viral infections: Knowledge gaps and research priorities

  2023cites this paper
• Therapeutic monitoring of serum concentrations of acyclovir and its metabolite 9-(carboxymethoxymethyl) guanine in routine clinical practice.

  2022cites this paper
• Shedding a Light on Acyclovir Pharmacodynamics: A Retrospective Analysis on Pharmacokinetic/Pharmacodynamic Modelling of Acyclovir for the Treatment of Varicella Zoster Virus Infection in Immunocompromised Patients: A Pilot Study

  2022cites this paper
• Effect of ketoprofen on intravenous pharmacokinetics of ganciclovir in chukar partridges (Alectoris chukar).

  2021cites this paper
• Quantum chemical computation and spectroscopic investigation on antiviral drug Acyclovir:-In-silico and in-vitro analysis

  2021cites this paper
• Developing a physiologically based pharmacokinetic model of apixaban to predict scenarios of drug–drug interactions, renal impairment and paediatric populations

  2021cites this paper
• Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation.

  2021cites this paper
• Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches

  2020cites this paper
• The Utility of Pharmacometric Models in Clinical Pharmacology Research in Infants

  2020cites this paper
• Effect of benzylpenicillin on intravenous pharmacokinetics of acyclovir in red-eared slider turtles (Trachemys scripta elegans).

  2020cites this paper
• Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

  2020cites this paper
• Population Pharmacokinetics of Intravenous and Oral Acyclovir and Oral Valacyclovir in Pediatric Population To Optimize Dosing Regimens

  2020cites this paper
• Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents

  2019cites this paper
• Pharmacokinetics and Pharmacodynamics of Antiviral Drugs in Special Population

  2019cites this paper
• Acyclovir in the Treatment of Herpes Viruses - a Review.

  2018cites this paper
• Suivi thérapeutique pharmacologique des antiviraux aciclovir et ganciclovir

  2018cites this paper
• Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study

  2018cites this paper
• Semi-Mechanistic Model for Predicting the Dosing Rate in Children and Neonates for Drugs Mainly Eliminated by Cytochrome Metabolism

  2018cites this paper
• Acyclovir chemical kinetics with the discovery and identification of newly reported degradants and degradation pathways involving formaldehyde as a degradant and reactant intermediate.

  2018cites this paper
• [Neonatal herpes: Epidemiology, clinical manifestations and management. Guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF)].

  2017cites this paper
• [Neonatal herpes: Epidemiology, clinical manifestations and management. Guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF)].

  2017cites this paper
• Efficacy of the early administration of valacyclovir hydrochloride for the treatment of neuropathogenic equine herpesvirus type-1 infection in horses.

  2017cites this paper
• Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients

  2016cites this paper
• Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates

  2016cites this paper
• Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults

  2016cites this paper
• Polish consensus guidelines on the use of acyclovir in the treatment and prevention of VZV and HSV infections.

  2016cites this paper
• Age Variation when Coining Drugs as High vs Low Hepatic Extraction Ratio

  2016cites this paper
• Considering Age Variation When Coining Drugs as High versus Low Hepatic Extraction Ratio

  2016cites this paper
• In search for effective and definitive treatment of herpes simplex virus type 1 (HSV-1) infections

  2016cites this paper
• Adsorptive Square Wave Voltammetric Determination of Acyclovir and Its Application in a Pharmacokinetic Study Using a Novel Sensor of β-Cyclodextrin Modified Pencil Graphite Electrode

  2015cites this paper
• Synthesis of hybrid polymer blend nanoparticles and incorporation into in situ gel foam spray for controlled release therapy using a versatile synthetic purine nucleoside analogue antiviral drug

  2015cites this paper
• Development of a paediatric population pharmacokinetic model for valacyclovir from literature non-compartmental values originating from sparse studies and Bayesian priors: a simulation study

  2015influential citation
• Neonatal formulary 7

  2015cites this paper
• Extrapolation of Valacyclovir Posology to Children Based on Pharmacokinetic Modeling

  2015influential citation
• Tramadol and O-Desmethyl Tramadol Clearance Maturation and Disposition in Humans: A Pooled Pharmacokinetic Study

  2015cites this paper
• La prevention et la prise en charge des infections par le virus de l’herpes simplex.

  2014cites this paper
• Prevention and management of neonatal herpes simplex virus infections.

  2014cites this paper
• Towards evidence based medicine for paediatricians

  2014cites this paper
• Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology

  2014cites this paper
• Pharmacokinetic studies in infants using minimal-risk study designs.

  2014cites this paper
• Paediatric oral biopharmaceutics: key considerations and current challenges.

  2014cites this paper
• Prediction of heptatic and renal clearance in pediatric populations: A "bottom-up" approach versus "top-down" recognition of covariates

  2013cites this paper
• Infections néonatales virales

  2013cites this paper
• Pharmacokinetics of ganciclovir and valganciclovir in the adult horse.

  2013influential citation
• Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development—Part 2: Introduction to Pharmacokinetic Modeling Methods

  2013cites this paper
• A pharmacokinetic standard for babies and adults.

  2013cites this paper
• Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban

  2013cites this paper
• Population Pharmacokinetic Analysis during the First 2 Years of Life

  2012cites this paper
• Prediction of morphine dose in humans

  2012cites this paper
• Pharmacokinetics and Pharmacodynamics of ASP2151, a Helicase-Primase Inhibitor, in a Murine Model of Herpes Simplex Virus Infection

  2012cites this paper
• Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4

  2011cites this paper
• Pharmacokinetic design optimization in children and estimation of maturation parameters : example of cytochrome P 450 3 A 4

  2011cites this paper
• Nonlinear Mixed Effects Models: Practical Issues

  2011cites this paper
• Pharmacokinetics of penciclovir after oral administration of its prodrug famciclovir to horses.

  2010cites this paper
• Use of antiviral medications against equine herpes virus associated disorders

  2010cites this paper
• Antiviral Drugs (Other than Antiretrovirals)

  2010cites this paper
• Single-Dose Pharmacokinetics of Famciclovir in Infants and Population Pharmacokinetic Analysis in Infants and Children

  2010cites this paper
• Developmental pharmacokinetics.

  2010cites this paper
• Developmental Pharmacogenetics of Immunosuppressants in Pediatric Organ Transplantation

  2010cites this paper
• Intravenous neonatal paracetamol dosing: the magic of 10 days

  2009cites this paper
• Human renal function maturation: a quantitative description using weight and postmenstrual age

  2009cites this paper
• Towards evidence based medicine for paediatricians. Does oral aciclovir improve clinical outcome in immunocompetent children with primary herpes simplex gingivostomatitis?

  2009cites this paper
• Optimizing Pediatric Dosing: A Developmental Pharmacologic Approach

  2009cites this paper
• Clinical Trial Simulations in Pediatric Patients Using Realistic Covariates: Application to Teduglutide, a Glucagon‐Like Peptide‐2 Analog in Neonates and Infants With Short‐Bowel Syndrome

  2009cites this paper
• Multiple oral dosing of valacyclovir in horses and ponies.

  2009influential citation
• Evaluation of orally administered valacyclovir in experimentally EHV1-infected ponies.

  2009cites this paper
• Population Pharmacokinetics of Acyclovir in Children and Young People with Malignancy after Administration of Intravenous Acyclovir or Oral Valacyclovir

  2009influential citation
• Pediatric pharmacology in the first year of life

  2009cites this paper
• Facilitation of Drug Evaluation in Children by Population Methods and Modelling

  2008cites this paper
• Pharmacokinetics of valacyclovir in the adult horse.

  2008cites this paper
• Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial.

  2008cites this paper
• Retrospective Population Pharmacokinetic Analysis of Levetiracetam in Children and Adolescents with Epilepsy

  2008cites this paper
• Pharmacokinetics of Acyclovir after Intravenous Infusion of Acyclovir and after Oral Administration of Acyclovir and Its Prodrug Valacyclovir in Healthy Adult Horses

  2007cites this paper
• Towards evidence-based medicine for paediatricians

  2006cites this paper
• Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.

  2006cites this paper
• Modelling and clinical trials in paediatrics.

  2005cites this paper
• Modélisation et essais cliniques en pédiatrie

  2005cites this paper
• Place des antiviraux dans la varicelle

  2005cites this paper
• Neonatal Herpes Infection: A

  2004cites this paper
• Neonatal herpes infection: a review

  2004cites this paper
• Herpes Simplex Virus

  2003cites this paper
• The pharmacokinetics of antiviral therapy in paediatric patients.

  2003cites this paper
• Pathogenesis and Immune Response

  2002cites this paper
• [Modalities of treatment local and general, medicamentous or not, controlling neonate suspected to be infected/contaminated by HSV1 or HSV2].

  2002cites this paper
• [Role of pharmacokinetic-pharmacodynamic relationships in drug development].

  2002cites this paper
• CHAPTER 8 Nonlinear Mixed Effects Models : Practical Issues

  year unknowncites this paper
• F UTURE J OURNAL OF P HARMACEUTICALS AND H EALTH S CIENCES

  year unknowncites this paper